Drug intelligence / Profile preview

Orthokure

Development stage: Unknown
Lead developer: Lord's Homoeopathic Laboratory
Modality: Small Molecules
Administration: Oral

Overview

Orthokure is a homeopathic oral tablet manufactured by Lord's Homeopathic Laboratory Pvt. Ltd. It is marketed as a vegan bone supplement containing a combination of glucosamine, curcumin, and boswellia. The product is formulated to support cartilage health, improve collagen and calcium levels, and maintain bone density. It is indicated for various joint-related conditions, including arthritis, rheumatism, joint pain, swelling, stiffness, and mineral deficiencies. The tablets are typically administered twice daily to facilitate mineral transport from the bloodstream to the bones and promote overall bone strength and flexibility.

Brand names: Orthokure
Other names: Orthokure Tablets

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)ALOX5 (Arachidonate 5-lipoxygenase)

Beyond the preview

Go deeper on Orthokure.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Orthokure.

Explore the full profile